Updated management for patients with cardiovascular disease and diabetes

被引：4

作者：

Dugan, Joy ^{[1
,5
]}

Butts, Amy ^{[1
,2
]}

Collins, Billy St John ^{[1
,3
]}

Saini, Parmjeet S. ^{[1
,4
]}

Bradley, Sarah ^{[6
]}

机构：

[1] Amer Diabet Assoc, Primary Care Advisory Grp, Arlington, VA 22202 USA

[2] Wheeling Hosp, Wellsburg, WV USA

[3] NHLBI, Cardiovasc Branch, Bldg 10, Bethesda, MD 20892 USA

[4] Ctr Medicare & Medicaid Serv, Northeast Div, Survey & Certificat Branch, Baltimore, MD USA

[5] Touro Univ Calif, Joint MSPAS MPH Program, Vallejo, CA USA

[6] Amer Diabet Assoc, Arlington, VA USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2019年 / 32卷 / 08期

关键词：

atherosclerotic cardiovascular disease; ASCVD diabetes; hypertension; lipid management; primary prevention; TYPE-2; HYPERTENSION; OUTCOMES;

D O I：

10.1097/01.JAA.0000569804.46658.ce

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality for patients with diabetes. The latest guidelines from the American Diabetes Association include new information on hypertension, lipid management, heart failure, and coronary heart disease. This year, for the first time, the cardiovascular disease and risk management section was endorsed by the American College of Cardiology. Primary and secondary prevention of ASCVD is a critical element of the primary care visit for patients with diabetes. This article provides key highlights that are important for busy clinicians.

引用

页码：51 / 53

页数：3

共 19 条

[11] Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes [J].

Marso, Steven P. ;

Daniels, Gilbert H. ;

Brown-Frandsen, Kirstine ;

Kristensen, Peter ;

Mann, Johannes F. E. ;

Nauck, Michael A. ;

Nissen, Steven E. ;

Pocock, Stuart ;

Poulter, Neil R. ;

Ravn, Lasse S. ;

Steinberg, William M. ;

Stockner, Mette ;

Zinman, Bernard ;

Bergenstal, Richard M. ;

Buse, John B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04) :311-322

[12] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes [J].

Neal, Bruce ;

Perkovic, Vlado ;

Mahaffey, Kenneth W. ;

de Zeeuw, Dick ;

Fulcher, Greg ;

Erondu, Ngozi ;

Shaw, Wayne ;

Law, Gordon ;

Desai, Mehul ;

Matthews, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07) :644-657

[13] Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis [J].

Palmer, Suetonia C. ;

Mavridis, Dimitris ;

Navarese, Eliano ;

Craig, Jonathan C. ;

Tonelli, Marcello ;

Salanti, Georgia ;

Wiebe, Natasha ;

Ruospo, Marinella ;

Wheeler, David C. ;

Strippoli, Giovanni F. M. .

LANCET, 2015, 385 (9982) :2047-2056

[14] Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome [J].

Pfeffer, Marc A. ;

Claggett, Brian ;

Diaz, Rafael ;

Dickstein, Kenneth ;

Gerstein, Hertzel C. ;

Kober, Lars V. ;

Lawson, Francesca C. ;

Ping, Lin ;

Wei, Xiaodan ;

Lewis, Eldrin F. ;

Maggioni, Aldo P. ;

McMurray, John J. V. ;

Probstfield, Jeffrey L. ;

Riddle, Matthew C. ;

Solomon, Scott D. ;

Tardif, Jean-Claude .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (23) :2247-2257

[15] Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes [J].

Weber, Michael A. ;

Bakris, George L. ;

Jamerson, Kenneth ;

Weir, Matthew ;

Kjeldsen, Sverre E. ;

Devereux, Richard B. ;

Velazquez, Eric J. ;

Dahlof, Bjorn ;

Kelly, Roxzana Y. ;

Hua, Tsushung A. ;

Hester, Allen ;

Pitt, Bertram .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (01) :77-85

[16] Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes [J].

Wing, Rena ;

Bolin, Paula ;

Brancati, Frederick L. ;

Bray, George A. ;

Clark, Jeanne M. ;

Coday, Mace ;

Crow, Richard S. ;

Curtis, Jeffrey M. ;

Egan, Caitlin M. ;

Espeland, Mark A. ;

Evans, Mary ;

Foreyt, John P. ;

Ghazarian, Siran ;

Gregg, Edward W. ;

Harrison, Barbara ;

Hazuda, Helen P. ;

Hill, James O. ;

Horton, Edward S. ;

Hubbard, Van S. ;

Jakicic, John M. ;

Jeffery, Robert W. ;

Johnson, Karen C. ;

Kahn, Steven E. ;

Kitabchi, Abbas E. ;

Knowler, William C. ;

Lewis, Cora E. ;

Maschak-Carey, Barbara J. ;

Montez, Maria G. ;

Murillo, Anne ;

Nathan, David M. ;

Patricio, Jennifer ;

Peters, Anne ;

Pi-Sunyer, Xavier ;

Pownall, Henry ;

Reboussin, David ;

Regensteiner, Judith G. ;

Rickman, Amy D. ;

Ryan, Donna H. ;

Safford, Monika ;

Wadden, Thomas A. ;

Wagenknecht, Lynne E. ;

West, Delia S. ;

Williamson, David F. ;

Yanovski, Susan Z. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) :145-154

[17]

Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI [10.1056/NEJMoa1812389, 10.1056/NEJMc1902837]

[18] Economic Costs of Diabetes in the US in 2017 [J].

Yang, Wenya ;

Dall, Timothy M. ;

Beronjia, Kaleigh ;

Lin, Janice ;

Semilla, April P. ;

Chakrabarti, Ritashree ;

Hogan, Paul F. .

DIABETES CARE, 2018, 41 (05) :917-928

[19] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].

Zinman, Bernard ;

Wanner, Christoph ;

Lachin, John M. ;

Fitchett, David ;

Bluhmki, Erich ;

Hantel, Stefan ;

Mattheus, Michaela ;

Devins, Theresa ;

Johansen, Odd Erik ;

Woerle, Hans J. ;

Broedl, Uli C. ;

Inzucchi, Silvio E. ;

Aizenberg, D. ;

Ulla, M. ;

Waitman, J. ;

De Loredo, L. ;

Farias, J. ;

Fideleff, H. ;

Lagrutta, M. ;

Maldonado, N. ;

Colombo, H. ;

Ferre Pacora, F. ;

Wasserman, A. ;

Maffei, L. ;

Lehman, R. ;

Selvanayagam, J. ;

d'Emden, M. ;

Fasching, P. ;

Paulweber, B. ;

Toplak, H. ;

Luger, A. ;

Drexel, H. ;

Prager, R. ;

Schnack, C. ;

Schernthaner, G. ;

Fliesser-Goerzer, E. ;

Kaser, S. ;

Scheen, A. ;

Van Gaal, L. ;

Hollanders, G. ;

Kockaerts, Y. ;

Capiau, L. ;

Chachati, A. ;

Persu, A. ;

Hermans, M. ;

Vantroyen, D. ;

Vercammen, C. ;

Van de Borne, P. ;

Mathieu, C. ;

Benhalima, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) :2117-2128

← 1 2 →